Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwin S Schultz

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Journal of Dermatology : EJD|October 15, 2015
Mucosal relapse one year after complete remission of cutaneous sporotrichoid leishmaniasis due to Leishmania braziliensisAngeliki A Ntasou, Hans Grummich, Klaus Fischer, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patientJanine Doesch, Dirk Debus, Christian Meyer, et al.
Oncology Reports|November 8, 2005
Artesunate in the treatment of metastatic uveal melanoma--first experiencesThomas G Berger, Detlef Dieckmann, Thomas Efferth, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2018
A case of multiple familial trichoepitheliomas responding to treatment with the Hedgehog signaling pathway inhibitor vismodegibVera Baur, Thomas Papadopoulos, Dmitry V Kazakov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturationNiels Schaft, Jan Dörrie, Peter Thumann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapyErwin S Schultz, Beatrice Schuler-Thurner, Vincent Stroobant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunityCornelia Erfurt, Zhaojun Sun, Ina Haendle, et al.
International Journal of Cancer|February 3, 2005
Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patientsChristian Maczek, Thomas G Berger, Beatrice Schuler-Thurner, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF<sup>V600</sup> mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trialLisa Zimmer, Elisabeth Livingstone, Angela Krackhardt, et al.
The Journal of Experimental Medicine|May 22, 2002
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cellsBeatrice Schuler-Thurner, Erwin S Schultz, Thomas G Berger, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Dermatology : EJD|October 15, 2015
Mucosal relapse one year after complete remission of cutaneous sporotrichoid leishmaniasis due to Leishmania braziliensisAngeliki A Ntasou, Hans Grummich, Klaus Fischer, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patientJanine Doesch, Dirk Debus, Christian Meyer, et al.
Oncology Reports|November 8, 2005
Artesunate in the treatment of metastatic uveal melanoma--first experiencesThomas G Berger, Detlef Dieckmann, Thomas Efferth, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2018
A case of multiple familial trichoepitheliomas responding to treatment with the Hedgehog signaling pathway inhibitor vismodegibVera Baur, Thomas Papadopoulos, Dmitry V Kazakov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturationNiels Schaft, Jan Dörrie, Peter Thumann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapyErwin S Schultz, Beatrice Schuler-Thurner, Vincent Stroobant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunityCornelia Erfurt, Zhaojun Sun, Ina Haendle, et al.
International Journal of Cancer|February 3, 2005
Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patientsChristian Maczek, Thomas G Berger, Beatrice Schuler-Thurner, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF<sup>V600</sup> mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trialLisa Zimmer, Elisabeth Livingstone, Angela Krackhardt, et al.
The Journal of Experimental Medicine|May 22, 2002
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cellsBeatrice Schuler-Thurner, Erwin S Schultz, Thomas G Berger, et al.
Pageof 3